190 related articles for article (PubMed ID: 27173185)
21. Breast Cancers of Special Histologic Subtypes Are Biologically Diverse.
Tadros AB; Wen HY; Morrow M
Ann Surg Oncol; 2018 Oct; 25(11):3158-3164. PubMed ID: 30094484
[TBL] [Abstract][Full Text] [Related]
22. Expression of DNA methylation-related proteins in invasive lobular carcinoma of breast: comparison to invasive ductal carcinoma.
Cha YJ; Kim HM; Koo JS
Histol Histopathol; 2017 Nov; 32(11):1175-1185. PubMed ID: 28111737
[TBL] [Abstract][Full Text] [Related]
23. Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis.
Korkola JE; DeVries S; Fridlyand J; Hwang ES; Estep AL; Chen YY; Chew KL; Dairkee SH; Jensen RM; Waldman FM
Cancer Res; 2003 Nov; 63(21):7167-75. PubMed ID: 14612510
[TBL] [Abstract][Full Text] [Related]
24. Secretome proteomics reveals candidate non-invasive biomarkers of BRCA1 deficiency in breast cancer.
Warmoes M; Lam SW; van der Groep P; Jaspers JE; Smolders YH; de Boer L; Pham TV; Piersma SR; Rottenberg S; Boven E; Jonkers J; van Diest PJ; Jimenez CR
Oncotarget; 2016 Sep; 7(39):63537-63548. PubMed ID: 27566577
[TBL] [Abstract][Full Text] [Related]
25. Single-Cell Transcriptomic Heterogeneity in Invasive Ductal and Lobular Breast Cancer Cells.
Chen F; Ding K; Priedigkeit N; Elangovan A; Levine KM; Carleton N; Savariau L; Atkinson JM; Oesterreich S; Lee AV
Cancer Res; 2021 Jan; 81(2):268-281. PubMed ID: 33148662
[TBL] [Abstract][Full Text] [Related]
26. Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal/lobular breast cancers but differ from pure invasive ductal breast cancers.
Bharat A; Gao F; Margenthaler JA
Am J Surg; 2009 Oct; 198(4):516-9. PubMed ID: 19800459
[TBL] [Abstract][Full Text] [Related]
27. Molecular and morphologic distinctions between infiltrating ductal and lobular carcinoma of the breast.
Yoder BJ; Wilkinson EJ; Massoll NA
Breast J; 2007; 13(2):172-9. PubMed ID: 17319859
[TBL] [Abstract][Full Text] [Related]
28. Expression of autophagy related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma.
Cha YJ; Kim YH; Cho NH; Koo JS
Int J Clin Exp Pathol; 2014; 7(6):3389-98. PubMed ID: 25031766
[TBL] [Abstract][Full Text] [Related]
29. Expression of sarcosine metabolism-related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma.
Cha YJ; Jung WH; Cho NH; Koo JS
Yonsei Med J; 2015 May; 56(3):598-607. PubMed ID: 25837163
[TBL] [Abstract][Full Text] [Related]
30. Differential Regulation and Targeting of Estrogen Receptor α Turnover in Invasive Lobular Breast Carcinoma.
Sreekumar S; Levine KM; Sikora MJ; Chen J; Tasdemir N; Carter D; Dabbs DJ; Meier C; Basudan A; Boone D; McAuliffe PF; Jankowitz RC; Lee AV; Atkinson JM; Oesterreich S
Endocrinology; 2020 Sep; 161(9):. PubMed ID: 32609836
[TBL] [Abstract][Full Text] [Related]
31. High-resolution genomic profiling reveals association of chromosomal aberrations on 1q and 16p with histologic and genetic subgroups of invasive breast cancer.
Stange DE; Radlwimmer B; Schubert F; Traub F; Pich A; Toedt G; Mendrzyk F; Lehmann U; Eils R; Kreipe H; Lichter P
Clin Cancer Res; 2006 Jan; 12(2):345-52. PubMed ID: 16428471
[TBL] [Abstract][Full Text] [Related]
32. Biologic markers in axillary node-negative breast cancer: differential expression in invasive ductal carcinoma versus invasive lobular carcinoma.
Gonzalez-Angulo AM; Sahin A; Krishnamurthy S; Yang Y; Kau SW; Hortobagyi GN; Cristofanilli M
Clin Breast Cancer; 2006 Dec; 7(5):396-400. PubMed ID: 17239264
[TBL] [Abstract][Full Text] [Related]
33. Chromatin accessibility landscape and active transcription factors in primary human invasive lobular and ductal breast carcinomas.
Lee S; Osmanbeyoglu HU
Breast Cancer Res; 2022 Jul; 24(1):54. PubMed ID: 35906698
[TBL] [Abstract][Full Text] [Related]
34. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
[TBL] [Abstract][Full Text] [Related]
35. The role of E-cadherin in low-grade ductal breast tumourigenesis.
Roylance R; Droufakou S; Gorman P; Gillett C; Hart IR; Hanby A; Tomlinson I
J Pathol; 2003 May; 200(1):53-8. PubMed ID: 12692841
[TBL] [Abstract][Full Text] [Related]
36. Gene Expression Analysis Identifies Common and Distinct Signatures Underlying Ductal and Lobular Breast Cancers.
Huang Q; Liu J; Chen T; Li L; Wang L; Wu Y
J Reprod Med; 2017; 62(5-6):271-83. PubMed ID: 30027719
[TBL] [Abstract][Full Text] [Related]
37. The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type.
Weigelt B; Geyer FC; Natrajan R; Lopez-Garcia MA; Ahmad AS; Savage K; Kreike B; Reis-Filho JS
J Pathol; 2010 Jan; 220(1):45-57. PubMed ID: 19877120
[TBL] [Abstract][Full Text] [Related]
38. [E-cadherin associated protein expression and its significance in invasive lobular carcinoma and invasive ductal carcinoma of breast].
Han A; Xiong M; Li Z; Liang Y
Zhonghua Bing Li Xue Za Zhi; 2001 Feb; 30(1):27-30. PubMed ID: 11866953
[TBL] [Abstract][Full Text] [Related]
39. Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers?
Sinha PS; Bendall S; Bates T
Eur J Surg Oncol; 2000 Dec; 26(8):733-7. PubMed ID: 11087636
[TBL] [Abstract][Full Text] [Related]
40. PDIA3 and PDIA6 gene expression as an aggressiveness marker in primary ductal breast cancer.
Ramos FS; Serino LT; Carvalho CM; Lima RS; Urban CA; Cavalli IJ; Ribeiro EM
Genet Mol Res; 2015 Jun; 14(2):6960-7. PubMed ID: 26125904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
